Previous Events

Amsterdam Barcelona Brussels Lisbon London Lyon

On the 26th of June, QUALITOP organised a public conference in Amsterdam, concentrating on the challenges and advancements in clinical trials and quality of life research, particularly [...]

On Wednesday, 26th June 2024, Amsterdam hosted a workshop on the QUALITOP project, a groundbreaking effort to improve cancer patients’ quality of life through digital technologies. This [...]

On Tuesday, 25th of June, we published the fourth newsletter from QUALITOP. An overview of the latest updates on the project and updates on upcoming events. Please click here to read the […]

Chimeric antigen receptor T-cell therapy, also known as CAR T-cell therapy, is a form of immunotherapy utilised in the treatment of cancer. For this therapy, a technique involves altering T […]

A significant stride towards enhancing the quality of life for cancer patients, Cancer Patients Europe (CPE) has joined the consortium to lend support to the mission of Qualitop and amplify […]

Abstract Introduction:  Immunotherapies, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy, have significantly improved the clinical outcomes of various [...]

Abstract Introduction:  Immune checkpoint inhibitors (ICIs) have revolutionized lung cancer treatment. However, it remains unclear as to whether changes in Health-Related Quality-of-Life (HRQoL) [...]

Abstract Objective To investigate associations between quality of life (QoL) and 1) immunotherapy and other cancer treatments received three months before QoL measurements, and 2) the [...]

On WEDNESDAY 22nd of March, we published the third newsletter from QUALITOP. An overview on the latest updates of the project. Please click here to read the full newsletter.